Klintoz Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 12.00 Cr
as on 04-01-2025
- Paid Up Capital ₹ 10.38 Cr
as on 04-01-2025
- Company Age 21 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 5.95 Cr
as on 04-01-2025
- Revenue 18.51%
(FY 2016)
- Profit 55.11%
(FY 2016)
- Ebitda 107.85%
(FY 2016)
- Net Worth -16.76%
(FY 2016)
- Total Assets 1.18%
(FY 2016)
About Klintoz Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 12.00 Cr and a paid-up capital of Rs 10.38 Cr.
The company has closed loans amounting to ₹5.95 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Raj Singh, Amita Singh, and Aditya Chowdhury serve as directors at the Company.
- CIN/LLPIN
U24239DL2003PTC121451
- Company No.
121451
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Jul 2003
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Klintoz Pharmaceuticals Private Limited offer?
Klintoz Pharmaceuticals Private Limited offers a wide range of products and services, including Antibiotic Injection, Ceftriaxone Injection, Antibiotic Tablets & Capsules, Azithromycin Tablets, Anti Infective Drugs & Medicines, Antibiotic Tablets, Capsule & Syrup, Cardiovascular Drugs & Medication, Diabetes Medicine.
Who are the key members and board of directors at Klintoz Pharmaceuticals?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Raj Singh  | Director | 23-Jul-2003 | Current |
| Amita Singh | Director | 02-Apr-2007 | Current |
| Aditya Chowdhury | Director | 30-Mar-2024 | Current |
Financial Performance of Klintoz Pharmaceuticals.
Klintoz Pharmaceuticals Private Limited, for the financial year ended 2016, experienced significant growth in revenue, with a 18.51% increase. The company also saw a substantial improvement in profitability, with a 55.11% increase in profit. The company's net worth observed a substantial decline by a decrease of 16.76%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Klintoz Pharmaceuticals?
In 2017, Klintoz Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Linkquest Energy Solutions Private LimitedActive 2 years 8 months
Aditya Chowdhury is a mutual person
- Mdm Communications And Technologies Private LimitedActive 1 year 6 months
Aditya Chowdhury is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Punjab National Bank Creation Date: 14 Feb 2007 | ₹5.95 Cr | Satisfied |
How Many Employees Work at Klintoz Pharmaceuticals?
Klintoz Pharmaceuticals has a workforce of 31 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Klintoz Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Klintoz Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
